I can see the genetics chapter starts at line 5762 (Chromosomes section). I now have all the content needed from my previous reads. Let me deliver the complete restart - Theory first, then all Q&A formats.
𧬠GENETICS AND HEALTH
Park's Textbook of Preventive & Social Medicine
Complete Study Material - Theory β Q&A
βββββββββββββββββββββββ
SECTION 1: FULL THEORY
βββββββββββββββββββββββ
π TOPIC 1: CHROMOSOMES - The Basics
What are Chromosomes?
Chromosomes are rod-like condensations of chromatin (DNA + proteins). They become visible in the nucleus only during cell division. They occur in pairs - one from father, one from mother.
Key numbers:
- Human total = 46 chromosomes (23 pairs)
- 22 pairs = autosomes
- 1 pair = sex chromosomes (XX in female, XY in male)
- Largest chromosome = ~7 ΞΌm; about 5 times the length of the shortest
Chromosome composition: Made of DNA biochemically; consist of genes arranged like beads on a necklace.
Other species chromosome numbers (memory fact):
| Species | Chromosome No. |
|---|
| Man | 46 |
| Fruit fly | 8 |
| Garden pea | 14 |
| Potato | 48 |
Karyotyping
The process of arranging chromosomes in standard order by size and shape into a karyogram.
Denver System of Classification (7 groups A-G):
| Group | Chromosomes |
|---|
| A | 1, 2, 3 (largest) |
| B | 4, 5 |
| C | 6, 7, 8, 9, 10, 11, 12 (+ X) |
| D | 13, 14, 15 |
| E | 16, 17, 18 |
| F | 19, 20 |
| G | 21, 22 (+ Y) |
Method of Chromosomal Study:
- Take peripheral blood (WBCs used most commonly)
- Culture in medium, incubate 3 days
- Add Colchicine β arrests cells in metaphase
- Further incubate 3-5 hours
- Place in hypotonic solution β cells swell, chromosomes disperse
- Fix, stain, photograph
- Arrange in karyotype
π TOPIC 2: CELL DIVISION
MITOSIS (Ordinary cell division)
- Each chromosome divides lengthwise into 2 sister chromatids
- Chromatids joined at centromere
- Chromatids separate β each goes to one daughter cell
- Result: 2 daughter cells, each with 46 chromosomes (diploid β diploid)
- Purpose: growth and repair of body cells
MEIOSIS (Reduction division)
- Occurs only in reproductive cells (gonads)
- 2 nuclear divisions but only 1 chromosome division
- Key events:
- Homologous chromosomes pair (synapsis)
- Chromosomes replicate into chromatids (held at centromere)
- Crossing over - redistribution of genetic material (prophase I)
- Homologous chromosomes separate β chromosome number halved to 23
- Cell divides β each daughter cell has 23 chromosomes
- Second meiotic division: centromeres divide, chromatids separate
- Final result: 4 daughter cells, each with 23 chromosomes (haploid)
- At fertilization: 23 + 23 = 46 restored
| Term | Number | Meaning |
|---|
| Diploid | 46 | Full complement (somatic cells) |
| Haploid | 23 | Half set (gametes) |
π TOPIC 3: CLASSIFICATION OF GENETIC DISORDERS
Three major categories:
GENETIC DISORDERS
βββ 1. Chromosomal Disorders
β βββ Sex chromosome disorders (Turner, Klinefelter, XXX, XYY)
β βββ Autosomal disorders (Down, Edwards, Patau)
βββ 2. Mendelian (Single Gene) Disorders
β βββ Autosomal Dominant (AD)
β βββ Autosomal Recessive (AR)
β βββ X-linked Recessive
βββ 3. Multifactorial (Polygenic) Disorders
(Diabetes, Hypertension, CHD, Schizophrenia)
π TOPIC 4: CHROMOSOMAL DISORDERS
How they arise - NON-DISJUNCTION
Failure of chromosomes to separate properly during meiosis β one gamete gets 2 copies, other gets none β after fertilization = trisomy (47) or monosomy (45)
A. SEX CHROMOSOME DISORDERS
1. Turner Syndrome (45,XO)
- Karyotype: 45,XO (only 45 chromosomes, missing one X)
- Sex: Female
- Features:
- Short stature
- Webbed neck
- Broad (shield-shaped) chest, widely spaced nipples
- Low posterior hairline
- Primary amenorrhoea (no menstrual periods)
- Streak gonads β infertile
- Coarctation of aorta (cardiovascular defect)
- Intelligence usually normal
- Incidence: 1 in 3000 female births
- Treatment: Estrogen replacement therapy, growth hormone
2. Klinefelter Syndrome (47,XXY)
- Karyotype: 47,XXY (extra X in male)
- Sex: Male
- Features:
- Tall stature
- Small testes (hypogonadism)
- Azoospermia β infertile
- Gynecomastia (breast development)
- Reduced intelligence
- Female body habitus
- Incidence: Most common sex chromosome abnormality in males; 1/500-1000 males
- Treatment: Testosterone replacement
3. Triple X Syndrome (47,XXX)
- Female with extra X
- Usually fertile, low IQ
- Often clinically normal
4. Double Y Syndrome (47,XYY)
- Male with extra Y
- Tall, normal fertility
- Aggressive behaviour reported in some
B. AUTOSOMAL DISORDERS
1. Down Syndrome (Trisomy 21) β Most Important
- Karyotype: 47 chromosomes, extra chromosome 21
- Cause: Non-disjunction during maternal meiosis (usually)
- Maternal age effect: Risk increases sharply after age 35 years
- Incidence: ~1 in 700 live births
Clinical features (Systematic):
Face/Head:
- Flat occiput (brachycephaly)
- Flat nasal bridge
- Upward slanting (Mongoloid) eyes
- Epicanthic folds
- Brushfield spots (speckled iris)
- Protruding tongue
- Low-set ears
Hands:
- Simian crease (single palmar crease)
- Short, broad hands
- Clinodactyly (incurved 5th finger)
Others:
- Mental retardation (IQ usually 40-70)
- Congenital heart disease (ASD, VSD, AVSD - commonest cause of death)
- Hypotonia
- Duodenal atresia
- Increased risk of leukaemia
- Alzheimer's disease in 4th decade
Types of Down syndrome:
| Type | % | Cause |
|---|
| Free trisomy 21 | 94% | Non-disjunction |
| Translocation | 4% | Chromosome 21 attached to 14 |
| Mosaicism | 2% | Non-disjunction after fertilization |
Prenatal Diagnosis:
- Amniocentesis (14-18 weeks)
- CVS (10-12 weeks)
- Maternal serum screening (Triple/Quad test)
2. Edwards Syndrome (Trisomy 18)
- Extra chromosome 18
- Severe mental retardation, early death (most die within 1 year)
3. Patau Syndrome (Trisomy 13)
- Extra chromosome 13
- Cleft palate, polydactyly, severe defects
4. Autosomal Monosomies
- Loss of entire autosome is very serious; fertilized ovum may not survive
- Extremely rare
π TOPIC 5: MENDELIAN DISORDERS
Mendel's Laws in Clinical Genetics
A. AUTOSOMAL DOMINANT (AD)
- One mutant gene is enough to cause disease
- Affected parent β produces 2 types of gametes: half with mutant, half normal
- Risk to each offspring: 50% (1 in 2)
- Both sexes equally affected
- Disease appears in every generation (no skipping)
- No carrier state (affected = diseased)
Examples:
- Achondroplasia (dwarfism)
- Huntington's disease (chorea)
- Neurofibromatosis
- Marfan syndrome
- Familial hypercholesterolaemia
- Adult polycystic kidney disease
- Hereditary spherocytosis
- Myotonic dystrophy
B. AUTOSOMAL RECESSIVE (AR)
- Two mutant genes needed (homozygous) to cause disease
- Parents are heterozygous carriers (outwardly normal)
- Risk to each offspring: 1 in 4 (25%)
- Risk of being a carrier: 2 in 4 (50%)
- Risk of being completely normal: 1 in 4 (25%)
- Consanguinity increases risk (related parents more likely to share same mutant gene)
- Disease can skip generations
Examples:
- Phenylketonuria (PKU)
- Cystic Fibrosis
- Sickle cell anaemia
- Thalassaemia
- Alkaptonuria
- Wilson's disease
- Galactosaemia
- Congenital adrenal hyperplasia
C. X-LINKED RECESSIVE
- Mutant gene on X chromosome
- Males (XY): Only one X, so mutant gene expresses itself (no normal allele to mask it) β affected
- Females (XX): If one X is mutant and one normal β carrier (normal allele masks mutant) β healthy
- Females affected only if homozygous (very rare)
Patterns of inheritance:
| Cross | Daughters | Sons |
|---|
| Affected father (X^a Y) Γ Normal mother (XX) | All carriers | All normal |
| Carrier mother (XX^a) Γ Normal father (XY) | 50% carriers, 50% normal | 50% affected, 50% normal |
Examples:
- Haemophilia A (Factor VIII deficiency) - classic example
- Haemophilia B (Factor IX - Christmas disease)
- Colour blindness
- Duchenne Muscular Dystrophy (DMD)
- G6PD deficiency
- Fragile X syndrome
Catalogue of Mendelian diseases (Park's figures):
- 793 autosomal dominant phenotypes
- 629 autosomal recessive traits
- 123 sex-linked diseases
- Combined incidence: ~1% of all live-born individuals
π TOPIC 6: SPECIFIC GENETIC DISEASES (High Yield)
1. SICKLE CELL ANAEMIA β
Type: Autosomal Recessive
Molecular Basis:
- Classic point mutation in DNA
- Single nucleotide change in beta-globin gene
- Glutamic acid (position 6) β replaced by Valine
- This produces abnormal HbS instead of HbA
Genotypes:
| Genotype | Condition | RBCs |
|---|
| HbA/HbA | Normal | Normal |
| HbA/HbS | Sickle cell trait (carrier) | Look abnormal under microscope but clinically healthy |
| HbS/HbS | Sickle cell anaemia | Severe; most die before puberty |
Why does sickling occur?
Most important factor: concentration of HbS in the individual red blood cell
Malaria connection:
- Sickle cell trait (heterozygous HbAS) protects against malaria
- Areas with highest sickle cell prevalence = areas with highest malaria
- This explains why the gene is maintained in African populations (balanced polymorphism)
Epidemiology:
- Prevalent among Blacks in Africa
- HbS gene in 8% of American Blacks
- 1 in 400 American Black births β child with sickle cell anaemia
- High incidence in certain regions of India
Clinical Features (onset in 1st year of life when HbF falls):
- Chronic illness, jaundice
- Hepatomegaly (spleen NOT palpable in adult life due to auto-splenectomy)
- Delayed puberty
- Enlarged heart, hyperdynamic precordium, systolic murmurs
- Non-healing ulcers on legs
- Chronic multisystem disease
- Death from organ failure between ages 20 and 40 years
Management:
- No specific treatment for primary disease
- Comprehensive medical management improves quality of life
- Prenatal diagnosis available: DNA from foetal cells directly examined
- Genetic counselling for at-risk couples
2. THALASSAEMIAS β
Type: Autosomal Recessive
Definition: Hereditary disorders due to reduced synthesis of globin chains (alpha or beta)
Pathophysiology:
Reduced globin chain β reduced Hb synthesis β defective haemoglobinization β hypochromic microcytic anaemia
Types and Causes:
| Type | Cause | Chain affected |
|---|
| Alpha thalassaemia | Gene deletion | Alpha-globin chain |
| Beta thalassaemia | Point mutations (usually) | Beta-globin chain |
Why onset after 6 months?
Because haemoglobin switches from HbF (fetal) β HbA (adult) at 6 months. Until then, HbF protects the infant.
Alpha thalassaemia spectrum (by number of gene deletions):
| Genes deleted | Condition | Severity |
|---|
| 1 gene (--/Ξ±Ξ±) | Silent carrier | Nil |
| 2 genes (--/Ξ±Ξ± or --/--) | Thalassaemia trait | Mild anaemia |
| 3 genes (--/--Ξ±) | HbH disease | Moderate |
| 4 genes (--/--) | Hydrops fetalis | Lethal in utero |
Beta thalassaemia spectrum:
| Type | Genotype | Severity |
|---|
| Thalassaemia minor (trait) | Ξ²/Ξ²o | Mild; carrier |
| Thalassaemia intermedia | Ξ²+/Ξ²+ | Moderate |
| Thalassaemia major | Ξ²o/Ξ²o | Severe; requires transfusions |
Thalassaemia Major Clinical Features:
- Severe anaemia from 6 months
- Massive splenomegaly and hepatomegaly
- Bone changes - "hair on end" on skull X-ray (expanded marrow)
- Growth retardation
- Frontal bossing, prominent cheekbones (thalassaemic facies)
- Iron overload from transfusions (haemosiderosis)
Management:
- Regular blood transfusions (every 3-4 weeks)
- Iron chelation: Desferrioxamine (prevents iron overload)
- Bone marrow transplant (potential cure)
- Prenatal diagnosis and genetic counselling
3. RHESUS SYSTEM & ERYTHROBLASTOSIS FOETALIS β
Rh System Genetics:
- Depends on 3 genes: C, D, E (and their alleles c, d, e)
- Most potent antigen = Antigen D
- "Rh positive" = possessing antigen D
- "Rh negative" = lacking antigen D
- In India: 93% of population are Rh positive
- In Northern Europe/North America: ~85% Rh positive
Erythroblastosis Foetalis (Rh Haemolytic Disease):
Mechanism:
- Rh-positive foetus + Rh-negative mother
- Foetal RBCs cross placenta β enter maternal circulation
- Mother produces Rh antibodies (sensitization)
- Usually first pregnancy is safe (sensitization occurs at delivery)
- In subsequent pregnancies: Maternal IgG antibodies (7S, "weak" albumin type) cross placenta
- Destroy foetal RBCs β haemolysis
Two types of Rh antibodies:
- "Strong" (saline) antibodies - do NOT cross placenta
- "Weak" (albumin/IgG, 7S gammaglobulin) - DO cross placenta β cause disease
Clinical spectrum (in foetus/neonate):
- Severe: Foetus killed in utero β miscarriage
- Moderate: Infant born with jaundice, anaemia, and oedema = Erythroblastosis foetalis / Hydrops fetalis
- Mild: Neonatal jaundice only
Prevention:
- Anti-D immunoglobulin (Rho-GAM): Given to Rh-negative mother within 72 hours of delivery of Rh-positive baby
- Prevents sensitization β protects future pregnancies
4. BLOOD GROUPS AND DISEASE
ABO group associations:
| Blood Group | Associated Disease |
|---|
| Group O | Duodenal ulcer, Gastric ulcer |
| Group A | Stomach cancer, Carcinoma cervix, Pernicious anaemia |
| Group A | Higher risk of thrombosis on oral contraceptives |
| Lack of group O | Rheumatic heart disease |
Significance: Demonstration of blood group-disease associations is an important contribution of human genetics to medicine.
5. PHENYLKETONURIA (PKU) β
Type: Autosomal Recessive
Defect: Deficiency of phenylalanine hydroxylase (enzyme that converts phenylalanine β tyrosine)
Consequence: Phenylalanine accumulates + toxic metabolites formed β brain damage
Also: Reduced tyrosine β reduced melanin β fair skin and hair
Clinical Features:
- Progressive mental retardation (if untreated)
- Fair skin, blonde hair, blue eyes
- Musty/mousy odour (phenylacetic acid in urine)
- Eczema
- Seizures
- Normal at birth (protected by maternal enzymes in utero)
Screening: Guthrie test (heel prick blood on filter card, collected at 5-10 days after birth)
Treatment: Low phenylalanine diet started early β completely prevents mental retardation
Lesson: Classic example of how early intervention prevents genetic disease from expressing itself
6. HAEMOPHILIA β
Type: X-linked Recessive
| Haemophilia A | Haemophilia B |
|---|
| Deficiency | Factor VIII | Factor IX |
| Other name | Classical haemophilia | Christmas disease |
| Frequency | 80% (more common) | 20% |
| Gene location | X chromosome | X chromosome |
Features:
- Males affected, females are carriers
- Prolonged bleeding after cuts, surgery
- Haemarthroses (bleeding into joints - most characteristic) β crippling arthropathy
- Muscle haematomas
- Intracranial bleeds (life-threatening)
Lab:
- Prolonged APTT (intrinsic pathway affected)
- Normal PT, BT, platelet count
Treatment:
- Factor VIII/IX replacement (concentrates or recombinant)
- DDAVP for mild Haemophilia A (releases stored Factor VIII)
- Gene therapy under trial
7. CYSTIC FIBROSIS β
Type: Autosomal Recessive; most common lethal genetic disorder in Caucasians
Gene: CFTR gene (Cystic Fibrosis Transmembrane conductance Regulator) on chromosome 7
Mutation: Most common = ΞF508 (deletion of phenylalanine at position 508)
Defect: Defective chloride ion transport β thick, viscid secretions in lungs, pancreas, GI tract, sweat glands
Clinical Features:
- Recurrent chest infections (Pseudomonas, Staph. aureus)
- Progressive bronchiectasis, respiratory failure
- Pancreatic insufficiency β malabsorption, steatorrhoea
- Failure to thrive in children
- Male infertility (absent vas deferens)
- Nasal polyps
- Meconium ileus at birth (in 10%)
Diagnosis: Sweat chloride test - >60 mEq/L is diagnostic (normal <40)
Treatment:
- Chest physiotherapy, antibiotics
- Pancreatic enzyme supplements
- DNase (reduces sputum viscosity)
- CFTR modulators (Ivacaftor, Lumacaftor - new therapies)
- Lung transplantation
π TOPIC 7: ROLE OF GENETIC PREDISPOSITION IN COMMON DISEASES
Although environment has traditionally been the main determinant, genetic make-up is becoming increasingly important as environmental control improves.
Cancer
- Not yet certain if most cancers are hereditary
- Genetic predisposition involved in 10-25% of breast or colon cancer cases
- DNA screening test for breast cancer being developed
- Multiple genes affect tumour susceptibility
Coronary Heart Disease (CHD)
- Environmental factors alone are NOT the only cause
- Family history reveals genetic risks
- High blood pressure and high cholesterol are genetically influenced
- Mapping human genome makes genetic predisposition to CHD easier to identify
Diabetes Mellitus
- IDDM (Type 1): Evidence from twin studies - higher concordance in identical twins (25-30%) vs non-identical twins (5-10%)
- 85% of diabetes in developed countries is Type 2 (NIDDM) - strong familial tendency
- Candidate for gene therapy of pancreatic tissue in future
Mental Disorders
- Family and twin studies demonstrate genetic predisposition
- Alzheimer's disease has strong familial tendency; caused by at least 4 different genes
- Schizophrenia: concordance in identical twins ~50%
π TOPIC 8: ADVANCES IN MOLECULAR GENETICS
DNA Technology
DNA has advantages for genetic diagnosis because:
- Every cell contains the full DNA complement
- Genes can be studied whether actively producing product or not
- Definitive diagnosis can be made in all genetic conditions
Major Techniques:
1. DNA Probes
- Specific sequences that bind to complementary DNA
- Allow genetic diagnosis and analysis of unknown sequences adjacent to known ones
2. DNA Sequencing
- Rapid analysis of unknown DNA
- Identification of mutations causing disease
3. Restriction Enzymes
- Cut DNA consistently only at specific sequences
- Simple, rapid diagnosis from extremely small tissue samples
- Even single-cell DNA analysis is possible
4. PCR (Polymerase Chain Reaction)
- Amplifies known DNA sequences
- Works from tiny samples; even a single cell
- Forms basis of most modern molecular diagnostics
5. FISH (Fluorescence In Situ Hybridization)
- Direct visualization of genes in relation to each other in the nucleus of a living cell
- New cytogenetic technique
6. Positional Cloning
- Uses genetic markers along the entire human genome
- Disease mutations can be rapidly assigned to chromosomal position
- Even small families (kindreds) can be examined
7. Recombinant DNA / Transgenic Applications
- Therapeutic agents produced from coding DNA:
- Insulin
- Erythropoietin
- Factor VIII
- Transgenic animals: animal models of human diseases created
- Site-specific mutagenesis: studying roles of specific genes in multifactorial diseases
π TOPIC 9: GENE THERAPY
Definition: Introduction of a gene sequence into a cell with the aim of modifying the cell's behaviour in a clinically relevant fashion
Uses:
- Correct a genetic mutation (e.g., Cystic fibrosis)
- Kill a cell (e.g., Cancer)
- Modify susceptibility (e.g., HIV infection)
Types:
| Type | Target | Inheritance | Ethics |
|---|
| Somatic gene therapy | Body (non-reproductive) cells | NOT inherited | Accepted |
| Germline gene therapy | Reproductive cells (eggs/sperm) | Inherited by offspring | Banned/Controversial |
Delivery Methods (Vectors):
- Viral vectors (most efficient): Retroviruses (integrate into genome), Adenoviruses (lung targeting), AAV
- Non-viral: Liposomes, naked DNA injection
First successful gene therapy: ADA deficiency (Adenosine Deaminase deficiency, a form of SCID - Severe Combined Immunodeficiency)
Conditions being targeted:
- Cystic Fibrosis
- Haemophilia A and B
- Duchenne Muscular Dystrophy
- Thalassaemia
- Cancer (experimental)
- HIV
Ethical issues:
- Long-term safety unknown
- Germline modification affects all future generations
- Equity of access
- Potential for "designer babies"
π TOPIC 10: GENETIC SCREENING & PRENATAL DIAGNOSIS
Types of Genetic Screening
(a) Population Screening
- Testing large populations for carrier status
- Example: Thalassaemia screening in high-prevalence areas
(b) Prenatal Diagnosis β
Methods and their timing:
| Method | Timing | What is detected |
|---|
| Amniocentesis | 14-18 weeks | Chromosomal anomalies, metabolic defects, neural tube defects (AFP) |
| CVS (Chorionic Villus Sampling) | 10-12 weeks | Chromosomal, DNA analysis; earlier than amniocentesis |
| Foetal blood sampling | 18-20 weeks | Haematological disorders |
| Ultrasonography | Various | Structural defects |
| Maternal serum AFP | 15-18 weeks | Neural tube defects (elevated AFP) |
| Triple/Quadruple test | 15-18 weeks | Down syndrome screening (AFP low, hCG high, estriol low) |
Indications for Amniocentesis (when parents willing to consider abortion):
- Mother aged 35 or more (high risk of Down syndrome)
- Previous child with Down syndrome or chromosomal anomaly
- Parents with chromosomal translocation
- Previous child with metabolic defect detectable by amniocentesis (e.g., neural tube defects - detected by elevated AFP in amniotic fluid)
- Family history of sex-linked genetic disease (to determine foetal sex)
Neural Tube Defects (NTD) screening:
- Maternal serum AFP elevated in NTDs (anencephaly, spina bifida)
- Confirmed by amniocentesis
(c) Neonatal (Newborn) Screening
Biochemical screening of newborn infants first used for PKU in 1966
- Heel-prick blood collected at 5-10 days after birth
- Blood on filter paper = Guthrie card β sent to screening lab
Conditions screened in newborns:
- PKU (Phenylketonuria) - Guthrie test
- Congenital hypothyroidism - TSH level
- Sickle cell disease - haemoglobin electrophoresis on Guthrie blood spots
- Cystic fibrosis - immunoreactive trypsin (IRT) in Guthrie blood spots
- Congenital dislocation of hip - clinical examination (Ortolani/Barlow test)
- G6PD deficiency
- Duchenne Muscular Dystrophy
- Congenital Adrenal Hyperplasia
Key fact: Congenital dislocation of hip can be simply corrected if detected in neonatal period.
π TOPIC 11: GENETIC COUNSELLING
Definition: A communication process by which persons at risk of a hereditary disorder are given information about:
- The nature and consequences of the disorder
- The probability of developing and transmitting it
- Ways to prevent or ameliorate it
Goals:
- Help at-risk couples make informed reproductive decisions
- Reduce population burden of genetic disease
Components:
- Accurate diagnosis
- Pedigree analysis
- Risk calculation (recurrence risk)
- Communication of risk
- Discussion of options (prenatal diagnosis, adoption, not having children)
- Psychological support
- Follow-up
Indications:
- Advanced maternal age (>35 years)
- Previous child with genetic disorder
- Family history of hereditary condition
- Consanguineous marriage
- Recurrent miscarriages (3+)
- Abnormal prenatal screening result
βββββββββββββββββββββββ
SECTION 2: EXAM Q&A
βββββββββββββββββββββββ
π LONG ANSWER QUESTIONS (LAQs)
LAQ 1: Classify genetic disorders. Describe chromosomal disorders with examples.
Answer outline:
- Introduction: Genetic disorders = chromosomal + Mendelian + multifactorial
- Chromosomes: structure, karyotype, Denver system
- Non-disjunction mechanism
- Sex chromosome disorders: Turner (45,XO), Klinefelter (47,XXY), Triple X, XYY - features of each
- Autosomal disorders: Down (Trisomy 21) in detail - cause, maternal age effect, features, types (free trisomy, translocation, mosaic), prenatal diagnosis
- Autosomal monosomy: rare, lethal
LAQ 2: Describe Mendelian inheritance patterns with examples and pedigree patterns.
Answer outline:
- Three patterns: AD, AR, X-linked recessive
- Autosomal dominant: mechanism, 50% risk, no carriers, examples (Achondroplasia, Huntington's)
- Autosomal recessive: mechanism, 25% risk, carrier state, consanguinity, examples (PKU, CF, Sickle cell)
- X-linked recessive: mechanism, males affected, females carriers, all daughters of affected father = carriers, all sons of affected father = normal; examples (Haemophilia, DMD)
- Catalogue figures from Park
LAQ 3: Write about advances in molecular genetics and gene therapy.
Answer outline:
- DNA technology: advantages of DNA for diagnosis
- PCR, restriction enzymes, DNA probes, sequencing, FISH, positional cloning
- Recombinant DNA: insulin, erythropoietin, Factor VIII
- Transgenic animals
- Gene therapy: definition, uses, somatic vs germline, vectors, first success (ADA), conditions targeted, ethics
LAQ 4: Describe prenatal diagnosis and genetic screening.
Answer outline:
- Population screening, prenatal diagnosis, neonatal screening
- Amniocentesis: timing (14-18 wks), indications (5 key indications), procedure
- CVS: timing (10-12 wks), advantages (earlier)
- Maternal serum AFP: NTDs
- Triple test: components, timing
- Neonatal screening: Guthrie card, timing (5-10 days), conditions screened
- Genetic counselling
π SHORT NOTES (SNs)
SN: Down Syndrome
- Trisomy 21 | 47 chromosomes | Non-disjunction
- Maternal age >35 years is major risk factor
- Features: flat face, epicanthic folds, Brushfield spots, simian crease, mental retardation, CHD (ASD/VSD), hypotonia
- Types: Free trisomy 94%, Translocation 4%, Mosaic 2%
- Prenatal diagnosis: amniocentesis, CVS, triple test
SN: Turner Syndrome
- 45,XO | Female | Short stature
- Webbed neck, primary amenorrhoea, streak gonads, coarctation of aorta
- Infertile | Intelligence normal
- 1/3000 female births | Rx: estrogen + GH
SN: Klinefelter Syndrome
- 47,XXY | Male | Tall
- Small testes, gynecomastia, azoospermia (infertile), low IQ
- Most common sex chromosome disorder in males
- Rx: Testosterone replacement
SN: Sickle Cell Anaemia
- AR | Point mutation in beta-globin gene (GluβVal) | HbS
- Heterozygotes: clinically healthy, protects against malaria
- Homozygotes: severe haemolytic anaemia, die before puberty
- Onset: 1st year (when HbF falls)
- Features: jaundice, hepatomegaly, no palpable spleen, leg ulcers, organ failure (age 20-40)
- No specific treatment; prenatal DNA diagnosis available
SN: Thalassaemia
- AR | Alpha: gene deletion; Beta: point mutations
- Hypochromic microcytic anaemia
- Onset after 6 months (HbF β HbA switch)
- Major: severe anaemia, splenomegaly, "hair on end" skull X-ray, iron overload
- Rx: transfusions, iron chelation, BMT
SN: Gene Therapy
- Definition: Introduction of gene sequence into cell to modify behaviour
- Uses: correct mutation (CF), kill cell (cancer), modify susceptibility (HIV)
- Types: Somatic (not inherited) vs Germline (inherited - banned)
- Vectors: viral (retrovirus, adenovirus) or non-viral (liposomes)
- First success: ADA deficiency
- Products via recombinant DNA: insulin, erythropoietin, Factor VIII
SN: Amniocentesis
- Timing: 14-18 weeks of pregnancy
- Sample: amniotic fluid β foetal cells β culture + karyotyping
- Also: biochemical analysis of fluid (AFP for NTDs)
- 5 Indications: maternal age >35, previous chromosomal child, parental translocation, previous metabolic defect child, sex determination for X-linked disease
- NTD detected by elevated AFP in amniotic fluid
SN: Genetic Counselling
- Communication process giving hereditary disorder information
- Components: diagnosis, pedigree, risk calculation, communication, options, support
- Indications: advanced maternal age, family history, consanguinity, recurrent miscarriages, abnormal screening
SN: Erythroblastosis Foetalis
- Rh+ foetus + Rh- mother
- Foetal RBCs cross placenta β mother makes anti-D antibodies (IgG/7S)
- IgG crosses placenta in subsequent pregnancies β destroys foetal RBCs
- Result: jaundice, anaemia, oedema (erythroblastosis foetalis)
- Prevention: Anti-D immunoglobulin within 72 hours of delivery
π DIFFERENCES
Diff 1: Mitosis vs Meiosis
| Feature | Mitosis | Meiosis |
|---|
| Cell type | Somatic | Reproductive (gonads) |
| Divisions | 1 | 2 |
| Daughter cells | 2 | 4 |
| Chromosome no. | 46β46 (diploid) | 46β23 (haploid) |
| Crossing over | No | Yes (Prophase I) |
| Homologue pairing | No | Yes |
| Purpose | Growth, repair | Gamete formation |
Diff 2: Autosomal Dominant vs Autosomal Recessive
| Feature | AD | AR |
|---|
| Genes needed | 1 mutant | 2 mutant |
| Carrier state | None | Yes |
| Risk (affected Γ normal) | 50% | 25% (if carrier Γ carrier) |
| Pattern | Every generation | Skips generations |
| Consanguinity risk | No | Yes |
| Examples | Achondroplasia, Huntington | PKU, Sickle cell, CF |
Diff 3: Turner vs Klinefelter
| Feature | Turner (45,XO) | Klinefelter (47,XXY) |
|---|
| Sex | Female | Male |
| Karyotype | 45 | 47 |
| Stature | Short | Tall |
| Gonads | Streak (infertile) | Small testes (infertile) |
| Intelligence | Normal | Reduced |
| Hallmark | Webbed neck | Gynecomastia |
| Incidence | 1/3000 females | 1/500-1000 males |
Diff 4: Alpha vs Beta Thalassaemia
| Feature | Alpha Thalassaemia | Beta Thalassaemia |
|---|
| Mechanism | Gene deletion | Point mutation |
| Chain reduced | Alpha | Beta |
| Onset | Can be in utero | After 6 months |
| Severe form | Hydrops fetalis (4 genes) | Thalassaemia major |
| HbF | Not protective | Persists (protective) |
Diff 5: Haemophilia A vs B
| Feature | Haemophilia A | Haemophilia B |
|---|
| Other name | Classical | Christmas disease |
| Deficiency | Factor VIII | Factor IX |
| Frequency | 80% | 20% |
| Inheritance | X-linked recessive | X-linked recessive |
| Lab (APTT) | Prolonged | Prolonged |
Diff 6: Amniocentesis vs CVS
| Feature | Amniocentesis | CVS |
|---|
| Timing | 14-18 weeks | 10-12 weeks |
| Sample | Amniotic fluid | Chorionic villi |
| Advantage | Also detects AFP (NTD) | Earlier diagnosis |
| Risk of miscarriage | ~0.5% | ~1% |
| Foetal sex | Yes | Yes |
Diff 7: Somatic vs Germline Gene Therapy
| Feature | Somatic | Germline |
|---|
| Target | Body cells | Reproductive cells |
| Inheritance | Not inherited | Inherited by offspring |
| Status | In use/trials | Banned (ethical) |
π ONE-LINERS (50 High-Yield)
- Normal diploid chromosome number in humans = 46
- Haploid number (in gametes) = 23
- Chromosomes are rod-like condensations of chromatin
- Chromosomes become visible only during cell division
- Biochemically, chromosomes are made of DNA
- Genes are arranged on chromosomes like beads on a necklace
- Colchicine arrests cells in metaphase
- Hypotonic solution causes chromosomes to disperse
- Karyotype = arrangement of chromosomes in standard order by size and shape
- Denver system classifies chromosomes into 7 groups (A-G)
- Mitosis produces 2 diploid daughter cells
- Meiosis produces 4 haploid daughter cells
- Crossing over occurs during Meiosis I (Prophase I)
- Non-disjunction = failure of chromosomes to separate during meiosis
- Down syndrome = Trisomy 21
- Turner syndrome karyotype = 45,XO
- Klinefelter syndrome karyotype = 47,XXY
- Most common chromosomal disorder in live births = Down syndrome
- Most common sex chromosome disorder in males = Klinefelter syndrome
- Turner syndrome hallmark = webbed neck + short stature
- Klinefelter syndrome hallmark = gynecomastia
- Maternal age >35 years increases risk of Down syndrome
- Autosomal dominant risk to offspring = 50%
- Autosomal recessive risk to offspring (both parents carriers) = 25%
- Classic example of sex-linked recessive = Haemophilia
- Carrier of X-linked disease = female (clinically normal)
- Affected father Γ normal mother β all daughters are carriers
- Combined incidence of Mendelian diseases = ~1% of live births
- Sickle cell anaemia = point mutation in beta-globin gene
- Amino acid substitution in sickle cell = Glutamic acid β Valine
- Sickle cell trait protects against malaria (balanced polymorphism)
- Most important factor influencing sickling = concentration of HbS in RBC
- Sickle cell anaemia onset = first year of life (when HbF falls)
- Alpha thalassaemia cause = gene deletion
- Beta thalassaemia cause = point mutation
- Thalassaemia clinical onset = after 6 months (HbFβHbA switch)
- PKU enzyme deficiency = phenylalanine hydroxylase
- PKU screening test = Guthrie test (heel prick)
- PKU Guthrie card collected at 5-10 days of age
- PKU odour = musty/mousy (phenylacetic acid)
- CF gene location = chromosome 7 (CFTR)
- CF diagnostic sweat chloride = >60 mEq/L
- Most common lethal autosomal recessive in Caucasians = Cystic Fibrosis
- Haemophilia A = Factor VIII deficiency
- Haemophilia B = Factor IX deficiency
- FISH = Fluorescence In Situ Hybridization (direct gene visualization in living cell)
- PCR = Polymerase Chain Reaction (DNA amplification)
- Restriction enzymes = cut DNA at specific sequences
- Products of recombinant DNA technology = insulin, erythropoietin, Factor VIII
- First gene therapy success = ADA deficiency
π MCQs (30 Questions)
Q1. Normal human somatic cell chromosome number:
a) 23 b) 44 c) 46 β d) 48
Q2. Colchicine is used in chromosomal study to:
a) Stain chromosomes b) Culture cells c) Arrest cells in metaphase β d) Swell cells
Q3. Hypotonic solution in chromosomal study causes:
a) Cell death b) DNA denaturation c) Cells to swell and chromosomes to disperse β d) Chromosome staining
Q4. Denver classification divides chromosomes into:
a) 5 groups b) 6 groups c) 7 groups (A-G) β d) 8 groups
Q5. Crossing over occurs during:
a) Mitosis b) Meiosis II c) Meiosis I (Prophase I) β d) Interphase
Q6. Down syndrome is due to trisomy of chromosome:
a) 21 β b) 18 c) 13 d) X
Q7. Turner syndrome karyotype:
a) 47,XXX b) 47,XXY c) 45,XO β d) 47,XYY
Q8. Klinefelter syndrome is characterized by:
a) Short stature b) Webbed neck c) Gynecomastia β d) Streak gonads
Q9. Incidence of Turner syndrome:
a) 1/500 females b) 1/1000 females c) 1/3000 females β d) 1/10000 females
Q10. Risk of Down syndrome increases markedly after maternal age:
a) 25 years b) 30 years c) 35 years β d) 40 years
Q11. In autosomal dominant inheritance, risk to offspring is:
a) 25% b) 50% β c) 75% d) 100%
Q12. In autosomal recessive with both parents as carriers, risk is:
a) 25% β b) 50% c) 75% d) 100%
Q13. In X-linked recessive, affected father Γ normal mother β daughters are:
a) All affected b) 50% affected c) All carriers β d) All normal
Q14. Sickle cell anaemia is caused by:
a) Gene deletion b) Chromosomal non-disjunction c) Point mutation in beta-globin β d) Translocation
Q15. Sickle cell trait provides protection against:
a) Typhoid b) TB c) Malaria β d) Cholera
Q16. Most important factor influencing rate of sickling:
a) Temperature b) pH c) Concentration of HbS in individual RBC β d) Oxygen tension
Q17. Sickle cell anaemia onset is in:
a) Birth b) 3 months c) First year (when HbF falls) β d) 5 years
Q18. Alpha thalassaemia is caused by:
a) Point mutation b) Translocation c) Gene deletion β d) Inversion
Q19. Clinical features of thalassaemia appear after:
a) Birth b) 3 months c) 6 months β d) 1 year
Q20. PKU is caused by deficiency of:
a) Tyrosinase b) Glucose-6-phosphatase c) Phenylalanine hydroxylase β d) Homogentisic acid oxidase
Q21. PKU screening test is:
a) ELISA b) Western blot c) Guthrie test β d) PCR
Q22. Cystic Fibrosis gene is located on chromosome:
a) 5 b) 6 c) 7 β d) 21
Q23. Diagnostic sweat chloride in CF:
a) >40 mEq/L b) >60 mEq/L β c) >80 mEq/L d) >100 mEq/L
Q24. Haemophilia B is deficiency of:
a) Factor VII b) Factor VIII c) Factor IX β d) Factor X
Q25. PCR is used to:
a) Cut DNA b) Visualize genes c) Sequence DNA d) Amplify DNA β
Q26. FISH allows:
a) Direct visualization of genes in nucleus of living cell β b) DNA amplification c) DNA cutting d) Gene insertion
Q27. First successful gene therapy was for:
a) ADA deficiency β b) CF c) Haemophilia d) Thalassaemia
Q28. Germline gene therapy is:
a) Currently in wide use b) Used for cancer c) Banned/controversial due to heritable effects β d) Non-viral method only
Q29. Amniocentesis is routinely indicated in maternal age:
a) >25 years b) >30 years c) >35 years β d) >40 years
Q30. Guthrie card blood is collected at:
a) Birth b) 1-2 days c) 5-10 days β d) 1 month
π FILL IN THE BLANKS (40 Questions)
- Normal human diploid chromosome number = 46
- Gametes (sperm/ova) contain _____ chromosomes = 23 (haploid)
- At fertilization, diploid number of _____ is restored = 46
- Chromosomes become visible only during _____ = cell division
- Biochemically, chromosomes are made of _____ = DNA (deoxyribonucleic acid)
- In mitosis, daughter cells have _____ chromosomes each = 46
- In meiosis, daughter cells have _____ chromosomes each = 23
- Crossing over occurs in _____ phase of meiosis = Prophase I (Meiosis I)
- _____ is used to arrest cells in metaphase = Colchicine
- _____ solution causes cells to swell for chromosome study = Hypotonic
- Denver classification divides chromosomes into _____ groups = 7 (A-G)
- Down syndrome = Trisomy _____ = 21
- Turner syndrome karyotype = _____ = 45,XO
- Klinefelter syndrome karyotype = _____ = 47,XXY
- Maternal age _____ years increases Down syndrome risk = >35
- Autosomal dominant risk to offspring = _____% = 50
- Autosomal recessive risk (carrier Γ carrier) = _____% = 25
- In X-linked recessive, affected father Γ normal female β daughters are _____ = all carriers
- Classic example of X-linked recessive disease = _____ = Haemophilia
- Total Mendelian diseases have combined incidence of _____% of live births = 1
- Sickle cell anaemia is caused by _____ mutation = point
- In sickle cell, _____ acid is replaced by _____ = Glutamic acid replaced by Valine
- Sickle cell trait protects against _____ = malaria
- Most important factor affecting sickling = _____ = concentration of HbS in individual RBC
- Sickle cell anaemia onset = _____ year of life = first
- Alpha thalassaemia mechanism = _____ = gene deletion
- Beta thalassaemia mechanism = _____ = point mutations
- Thalassaemia features appear after _____ months = 6
- PKU enzyme deficiency = _____ = phenylalanine hydroxylase
- PKU urine odour = _____ = musty/mousy
- PKU screening = _____ test = Guthrie
- Guthrie blood collected at _____ days = 5-10
- CF gene = _____ on chromosome 7 = CFTR
- CF sweat chloride diagnostic value = >_____ mEq/L = 60
- Haemophilia A = Factor _____ deficiency = VIII
- Haemophilia B = Factor _____ deficiency = IX
- PCR = _____ chain reaction = Polymerase
- FISH = _____ = Fluorescence In Situ Hybridization
- Products of recombinant DNA: _____, _____, _____ = insulin, erythropoietin, Factor VIII
- Somatic gene therapy effects are _____ inherited = NOT
π MEMORY AIDS (Mnemonics)
| Mnemonic | Remembers |
|---|
| "21 DOWN the stairs" | Down = Trisomy 21 |
| "Turner is X-tra small girl" | 45,XO = short female |
| "Kline has X-tra man boobs" | 47,XXY = gynecomastia |
| "DOCTOR'S CAR" (AD examples) | Dwarfism, OculopharyngealMD, Chorea(Huntington), TOPBMI, Osteogenesis imperfecta, Retinoblastoma, Spherocytosis, Colon polyps (FAP), Achondroplasia, Retinal blastoma |
| "PKU = Poor Kid Urine (musty)" | Musty odour in PKU |
| "CF = Chloride Failure >60" | Sweat Cl >60 mEq/L |
| "A8 B9" | Haemophilia A=FVIII, B=FIX |
| "PCR = Photocopier for DNA" | PCR amplifies DNA |
| "FISH sees genes live" | FISH = visualization in living cell |
| "Guthrie at 5-10 days" | Neonatal screening timing |
| "Alpha DELetes, Beta POINTs" | Alpha = deletion, Beta = point mutation |
| "Sickle + Africa = Malaria protection" | Balanced polymorphism |
Source: Park's Textbook of Preventive and Social Medicine - Genetics and Health (Block 11)
(Park's PSM, 9789382219163)